You are viewing the site in preview mode
Skip to main content
|
Group
|
n
|
CD19+ CD69+ (%)
|
|---|
|
Myocardium
|
Spleen
|
Blood
|
|---|
|
AMI 3d
|
8
|
10.62 ± 1.62*#
|
6.05 ± 0.73*#
|
5.32 ± 0.73*#
|
|
Sham 3d
|
6
|
3.72 ± 0.51
|
3.62 ± 0.36
|
2.29 ± 0.43
|
|
AMI 5d
|
8
|
22.71 ± 3.43*
|
12.40 ± 2.07*
|
6.82 ± 0.77*
|
|
Sham 5d
|
6
|
3.75 ± 0.29
|
3.80 ± 0.40
|
2.76 ± 0.39
|
|
AMI 1W
|
8
|
7.62 ± 1.74*#
|
4.02 ± 0.58*#
|
3.60 ± 0.73#
|
|
Sham 1W
|
6
|
3.53 ± 0.65
|
3.71 ± 0.56
|
2.84 ± 0.55
|
|
AMI 2W
|
8
|
4.45 ± 0.75#
|
4.13 ± 0.82#
|
3.10 ± 0.58#
|
|
Sham 2W
|
6
|
3.40 ± 0.44
|
3.58 ± 0.59
|
2.58 ± 0.67
|
- *P < 0.05, the activated B cell ratio of AMI group was compared with the corresponding subgroups of the Sham group
- #P < 0.05, the activated B cell ratio of other subgroups of the AMI group was compared with AMI 5 days subgroups. Data are represented by mean ± standard deviation
